Published in Medicine (Baltimore) on July 01, 2016
The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) (1977) 9.53
The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) (1995) 8.80
Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet (1992) 6.28
Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71
Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut (1994) 2.14
Mapping the major susceptibility loci for familial Graves' and Hashimoto's diseases: evidence for genetic heterogeneity and gene interactions. J Clin Endocrinol Metab (1999) 1.20
Helicobacter pylori infection and endocrine disorders: is there a link? World J Gastroenterol (2009) 1.17
Sibling recurrence risk in autoimmune thyroid disease. Thyroid (2003) 1.00
Outcomes of children with hashitoxicosis. Horm Res Paediatr (2012) 0.99
Serum thyrotrophin and the response to thyrotrophin releasing hormone in symptomless autoimmune thyroiditis and in borderline and overt hypothyroidism. Acta Endocrinol (Copenh) (1974) 0.99
Helicobacter pylori infection is markedly increased in patients with autoimmune atrophic thyroiditis. J Clin Gastroenterol (1998) 0.99
Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol (2014) 0.97
Helicobacter pylori infection in spouses of patients with duodenal ulcers and comparison of ribosomal RNA gene patterns. Gut (1996) 0.94
The infection by Helicobacter pylori strains expressing CagA is highly prevalent in women with autoimmune thyroid disorders. J Physiol Pharmacol (1999) 0.93
Familial and community environmental risk factors for Helicobacter pylori infection in children and adolescents. J Pediatr Gastroenterol Nutr (2001) 0.93
Effect of desiccated thyroid in lymphocytic (Hashimoto's) thyroiditis. J Clin Endocrinol Metab (1959) 0.92
Seroprevalence, correlates and trends of Helicobacter pylori infection in the Israeli population. Epidemiol Infect (2011) 0.90
Helicobacter pylori infection in patients with Hashimoto's thyroiditis. Helicobacter (2004) 0.87
Is there anything to the reported association between Helicobacter pylori infection and autoimmune thyroiditis? Dig Dis Sci (2005) 0.85
Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients. J Clin Endocrinol Metab (1980) 0.84
Atrophic gastritis and the risk of incident colorectal cancer. Cancer Causes Control (2009) 0.83
Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis. Thyroid (2013) 0.83
Organ-specific autoantibodies in children with Helicobacter pylori infection. Helicobacter (2004) 0.78
The association of Helicobacter pylori infection with Hashimoto's thyroiditis. Acta Med Iran (2013) 0.77
Cell-replacement therapy for diabetes: Generating functional insulin-producing tissue from adult human liver cells. Proc Natl Acad Sci U S A (2005) 1.93
Glucocorticoid regimens for prevention of Graves' ophthalmopathy progression following radioiodine treatment: systematic review and meta-analysis. Thyroid (2014) 1.58
Illness perception in patients with differentiated epithelial cell thyroid cancer. Thyroid (2009) 1.47
Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms. Endocr Relat Cancer (2008) 1.25
Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis. J Clin Endocrinol Metab (2009) 1.24
Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. J Clin Endocrinol Metab (2013) 1.24
Medullary thyroid cancer: a retrospective analysis of a cohort treated at a single tertiary care center between 1970 and 2005. Thyroid (2007) 1.16
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients. Cancer (2006) 1.13
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia and the associated lung neuroendocrine tumors: clinical experience with a rare entity. Cancer (2011) 1.05
Hypopituitarism patterns and prevalence among men with macroprolactinomas. Pituitary (2015) 0.97
Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial. J Clin Endocrinol Metab (2015) 0.93
Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid (2010) 0.90
The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells. Mol Cell Endocrinol (2009) 0.89
PI3K/Akt/mTOR and Raf/MEK/ERK signaling pathways perturbations in non-functioning pituitary adenomas. Endocrine (2012) 0.86
Comparison of perioperative management and outcome of parathyroidectomy between older and younger patients. Head Neck (2008) 0.86
Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours. Eur J Endocrinol (2008) 0.85
The cell adhesion molecules N-cadherin and neural cell adhesion molecule regulate human growth hormone: a novel mechanism for regulating pituitary hormone secretion. J Clin Endocrinol Metab (2003) 0.84
Nitric oxide stimulates growth hormone secretion from human fetal pituitaries and cultured pituitary adenomas. Endocrine (2005) 0.83
Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro. Endocr Relat Cancer (2009) 0.83
Impact of pregnancy on outcome and prognosis of survivors of papillary thyroid cancer. Thyroid (2010) 0.83
Peptide receptor radioligand therapy is an effective treatment for the long-term stabilization of malignant gastrinomas. Cancer (2010) 0.83
Elevated white blood cell counts in Cushing's disease: association with hypercortisolism. Pituitary (2014) 0.82
Cortistatin inhibits growth hormone release from human fetal and adenoma pituitary cells and prolactin secretion from cultured prolactinomas. J Clin Endocrinol Metab (2006) 0.82
Papillary thyroid cancer: factors involved in restaging N1 disease after total thyroidectomy and radioactive iodine treatment. J Clin Endocrinol Metab (2014) 0.79
Elevated insulin-like growth factor-1 and insulin-like growth factor binding protein-2 in malignant pleural effusion. Acta Oncol (2002) 0.78
Efficacy of long-term lanreotide treatment in patients with acromegaly. Pituitary (2009) 0.78
The role of cell lines in the study of neuroendocrine tumors. Neuroendocrinology (2012) 0.78
Well-differentiated thyroid carcinoma: comparison of microscopic and macroscopic disease. Thyroid (2009) 0.77
Metastatic bronchial neuroendocrine tumor to the pineal gland: a unique manifestation of a rare disease. Hormones (Athens) (2010) 0.77
Clinical and biochemical stabilization of Nelson's syndrome with long-term low-dose cabergoline treatment. Pituitary (2006) 0.77
TSH-secreting pituitary adenomas: follow-up of 11 cases and review of the literature. Pituitary (2007) 0.77
Missense mutation in the MEN1 gene discovered through whole exome sequencing co-segregates with familial hyperparathyroidism. Genet Res (Camb) (2013) 0.77
Evaluation of leptin levels among fibromyalgia patients before and after three months of treatment, in comparison with healthy controls. Pain Res Manag (2012) 0.76
Pituitary imaging findings in male patients with hypogonadotrophic hypogonadism. Pituitary (2015) 0.76
Heparanase is highly expressed and regulates proliferation in GH-secreting pituitary tumor cells. Endocrinology (2011) 0.76
Unusual clinical presentations of giant prolactinomas. Pituitary (2011) 0.76
Current approach to treatments for prolactinomas. Minerva Endocrinol (2015) 0.75
LONG TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CANCER AND DISTANT METASTASES. Endocr Pract (2017) 0.75
Radiation-Induced Well-Differentiated Thyroid Cancer: Disease Characteristics and Survival. Isr Med Assoc J (2016) 0.75
Increased MIB-1/Ki-67 labeling index as a predictor of an aggressive course in a case of prolactinoma. Horm Res (2003) 0.75
Parathyroid cyst. Thyroid (2004) 0.75
CENTRAL DIABETES INSIPIDUS: CLINICAL CHARACTERISTICS AND LONG-TERM COURSE IN A LARGE COHORT OF ADULTS. Endocr Pract (2017) 0.75
Fulminant ectopic Cushing syndrome in a patient with metastatic neuroendocrine carcinoma and Crohn's disease. Neuro Endocrinol Lett (2011) 0.75
Combination of mTOR Inhibitors Augments Potency while Activating PI3K Signaling in Pituitary Tumors. Neuroendocrinology (2015) 0.75
Melanin-concentrating hormone stimulates human growth hormone secretion: a novel effect of MCH on the hypothalamic-pituitary axis. Am J Physiol Endocrinol Metab (2006) 0.75
SHORT-TERM DECLINE IN PROLACTIN CONCENTRATIONS CAN PREDICT FUTURE PROLACTIN NORMALIZATION, TUMOR SHRINKAGE, AND TIME TO REMISSION IN MEN WITH MACROPROLACTINOMAS. Endocr Pract (2015) 0.75
VARIATIONS IN CLINICAL AND IMAGING FINDINGS BY TIME OF DIAGNOSIS IN FEMALES WITH HYPOPITUITARISM ATTRIBUTED TO LYMPHOCYTIC HYPOPHYSITIS. Endocr Pract (2015) 0.75
Cortistatin - a new neuroendocrine hormone? Pediatr Endocrinol Rev (2007) 0.75